ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
2.030
-0.090 (-4.25%)
Dec 27, 2024, 4:00 PM EST - Market closed
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $196.28 million as of December 27, 2024. Its market cap has increased by 44.63% in one year.
Market Cap
196.28M
Enterprise Value
376.40M
1-Year Change
44.63%
Ranking
Category
Stock Price
$2.03
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $196.28M, a decrease of -90.39%. That is a compound annual growth rate of -39.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 27, 2024 | 196.28M | 46.37% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | 2.48B | 21.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mersana Therapeutics | 200.12M |
| Inhibikase Therapeutics | 198.89M |
| Stereotaxis | 198.27M |
| MultiPlan | 197.94M |
| Accuray | 195.10M |
| Myomo | 194.18M |
| Acrivon Therapeutics | 193.98M |
| MediWound | 193.03M |